Rxo Inc (NYSE:RXO - Get Free Report) has earned an average rating of "Hold" from the seventeen brokerages that are currently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and three have assigned a buy rating to the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $17.0769.
A number of equities analysts have commented on the stock. Cowen reiterated a "hold" rating on shares of RXO in a report on Friday, August 8th. Morgan Stanley reduced their price objective on shares of RXO from $23.00 to $21.00 and set an "equal weight" rating for the company in a research note on Monday, July 7th. Barclays decreased their target price on shares of RXO from $18.00 to $17.00 and set an "overweight" rating for the company in a research report on Tuesday, August 12th. JPMorgan Chase & Co. cut their price target on shares of RXO from $15.00 to $14.00 and set an "underweight" rating on the stock in a report on Tuesday, July 8th. Finally, UBS Group increased their price objective on RXO from $15.00 to $17.00 and gave the company a "neutral" rating in a report on Friday.
Get Our Latest Report on RXO
RXO Stock Up 5.2%
RXO stock opened at $17.50 on Tuesday. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.24. The firm has a market cap of $2.87 billion, a P/E ratio of -8.10, a P/E/G ratio of 7.70 and a beta of 1.65. The business has a fifty day moving average of $15.90 and a two-hundred day moving average of $15.78. RXO has a twelve month low of $12.19 and a twelve month high of $31.98.
RXO (NYSE:RXO - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.04 EPS for the quarter, topping the consensus estimate of $0.02 by $0.02. The firm had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.44 billion. RXO had a positive return on equity of 1.18% and a negative net margin of 5.45%.The business's revenue for the quarter was up 52.6% compared to the same quarter last year. During the same period in the previous year, the company posted $0.03 EPS. On average, analysts forecast that RXO will post 0.31 earnings per share for the current fiscal year.
Institutional Investors Weigh In On RXO
Institutional investors have recently added to or reduced their stakes in the business. AlphaQuest LLC acquired a new position in shares of RXO during the second quarter valued at about $29,000. Geneos Wealth Management Inc. acquired a new position in RXO during the 1st quarter valued at approximately $30,000. Larson Financial Group LLC raised its holdings in shares of RXO by 1,990.2% in the first quarter. Larson Financial Group LLC now owns 1,714 shares of the company's stock worth $33,000 after buying an additional 1,632 shares during the last quarter. CWM LLC lifted its stake in shares of RXO by 234.4% during the first quarter. CWM LLC now owns 1,876 shares of the company's stock worth $36,000 after buying an additional 1,315 shares during the period. Finally, Thurston Springer Miller Herd & Titak Inc. grew its holdings in shares of RXO by 52.5% during the first quarter. Thurston Springer Miller Herd & Titak Inc. now owns 2,745 shares of the company's stock valued at $52,000 after buying an additional 945 shares during the last quarter. Institutional investors and hedge funds own 92.73% of the company's stock.
About RXO
(
Get Free Report)
RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider RXO, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RXO wasn't on the list.
While RXO currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.